CYP3A Activity and Rivaroxaban Serum Concentrations in Russian Patients with Deep Vein Thrombosis.
| Author | |
|---|---|
| Abstract |
:
Rivaroxaban is metabolized in the liver via CYP3A4, the cytochrome involved in the metabolism of nearly 50% of all medications. Thus, its effective concentration depends on multiple pharmacologic parameters. |
| Year of Publication |
:
2018
|
| Journal |
:
Genetic testing and molecular biomarkers
|
| Volume |
:
22
|
| Issue |
:
1
|
| Number of Pages |
:
51-54
|
| ISSN Number |
:
1945-0265
|
| DOI |
:
10.1089/gtmb.2017.0152
|
| Short Title |
:
Genet Test Mol Biomarkers
|
| Download citation |
